Home › Funds › C WorldWide Group Holding A/S › NVCR

C WorldWide Group Holding A/S position in NVCR

NOVOCURE LTD · Health Care

C WorldWide Group Holding A/S reported holding 971,784 shares of NVCR (NOVOCURE LTD) in its Q3 2026 13F filing — a position valued at US$15.5M, representing 0.39% of its reported portfolio and ranking #41 among its reported holdings. C WorldWide Group Holding A/S has disclosed NVCR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)971.78K sh
Reported value held$15.50M
Portfolio Weight0.39%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How C WorldWide Group Holding A/S's NVCR position evolved

C WorldWide Group Holding A/S first disclosed a stake in NVCR in Q3 2023 at 221,784 shares (US$3.6M). The position peaked in Q4 2024 at 621,784 shares, worth US$18.5M. Across 13 filings, C WorldWide Group Holding A/S increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 9 time(s). The most recent filing (Q3 2026) shows 971,784 shares valued at US$15.5M. Notable position changes include a 135% increase in Q4 2023 (shares rose 5% over the following quarter), a 56% increase in Q3 2025 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 221.78K $3.58M New
Q4 2023 521.78K $7.79M Add
Q1 2024 521.78K $8.15M Hold
Q2 2024 521.78K $8.94M Hold
Q3 2024 521.78K $8.15M Hold
Q4 2024 621.78K $18.53M Add
Q1 2025 621.78K $11.08M Hold
Q2 2025 621.78K $11.07M Hold
Q3 2025 971.78K $12.55M Add
Q4 2025 971.78K $12.56M Hold
Q1 2026 971.78K $10.59M Hold
Q2 2026 971.78K $14.72M Hold
Q3 2026 971.78K $15.50M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NVCR and 13F data

NVCR (NOVOCURE LTD) is a Health Care company. 28 other funds we track also report a position in NVCR — the largest reported positions include Soleus Capital Management, L.P. (US$150.2M), Palo Alto Investors LP (US$19.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NVCR

All NVCR fund holders →

FAQ

How long has C WorldWide Group Holding A/S held NVCR?

C WorldWide Group Holding A/S has disclosed NVCR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is C WorldWide Group Holding A/S's current position in NVCR?

As of Q3 2026, C WorldWide Group Holding A/S holds 971.78K shares of NVCR (NOVOCURE LTD), valued at $15.50M, representing 0.39% of its reported portfolio and ranking #41.

Has C WorldWide Group Holding A/S been buying or selling NVCR?

In the latest 13F filing (Q3 2026), C WorldWide Group Holding A/S held unchanged its position in NVCR. The position peaked in Q4 2024 at 621.78K shares.

Which other funds hold NVCR?

Other major institutional holders of NVCR include Soleus Capital Management, L.P., Palo Alto Investors LP, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.